• 1216 Citations
  • 19 Scopus h-Index
20052020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article

Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma

Stewart, A. K., Krishnan, A. Y., Singhal, S., Boccia, R. V., Patel, M. R., Niesvizky, R., Chanan-Khan, A. A., Ailawadhi, S., Brumm, J., Mundt, K. E., Hong, K., McBride, J., Shon-Nguyen, Q., Xiao, Y., Ramakrishnan, V., Polson, A. G., Samineni, D., Leipold, D., Humke, E. W., McClellan, J. S. & 1 others, Berdeja, J. G., Feb 1 2019, In : Blood cancer journal. 9, 2, 17.

Research output: Contribution to journalArticle

Open Access
6 Scopus citations

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma

Paludo, J., Mikhael, J. R., Laplant, B. R., Halvorson, A. E., Kumar, S., Gertz, M. A., Hayman, S. R., Buadi, F. K., Dispenzieri, A., Lust, J. A., Kapoor, P., Leung, N., Russell, S. J., Dingli, D., Go, R. S., Lin, Y., Gonsalves, W. I., Fonseca, R., Bergsagel, P. L., Roy, V. & 8 others, Sher, T., Chanan-Khan, A. A., Ailawadhi, S., Stewart, A. K., Reeder, C. B., Richardson, P. G., Rajkumar, S. V. & Lacy, M. Q., Sep 7 2017, In : Blood. 130, 10, p. 1198-1204 7 p.

Research output: Contribution to journalArticle

31 Scopus citations

Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial

Ailawadhi, S., Mikhael, J. R., Laplant, B. R., Laumann, K. M., Kumar, S. K., Roy, V., Dingli, D. M., Bergsagel, P. L., Buadi, F. K., Rajkumar, S. V., Fonseca, R., Gertz, M., Kapoor, P., Sher, T., Hayman, S. R., Stewart, A. K., Dispenzieri, A., Kyle, R. A., Gonsalves, W., Reeder, C. B. & 8 others, Lin, Y., Go, R. S., Leung, N., Kourelis, T., Lust, J. A., Russell, S. J., Chanan Khan, A. A. & Lacy, M., Mar 1 2018, In : Leukemia. 32, 3, p. 719-728 10 p.

Research output: Contribution to journalArticle

9 Scopus citations

Predictors of palliative treatment in stage IV colorectal cancer

Osagiede, O., Spaulding, A., Frank, R. D., Merchea, A., Uitti, R., Ailawadhi, S., Kelley, S. & Colibaseanu, D., Jan 1 2018, (Accepted/In press) In : American Journal of Surgery.

Research output: Contribution to journalArticle

Prevalence of BCL-2/J(H) Translocation in Healthy African Americans

Colon-Otero, G., Van Wier, S. A., Ahmann, G. J., Braggio, E. D., Albertie, M. L., Weis, J. A., Ailawadhi, S., Cerhan, J. R., Vishnu, P., Jorgensen, M. S., Foran, J. M., Thomas, C. S. & Fonseca, R., Jan 1 2017, In : Annals of Hematology. 96, 1, p. 51-55 5 p.

Research output: Contribution to journalArticle

Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: A SEER-Medicare analysis

Ailawadhi, S., Parikh, K., Abouzaid, S., Zhou, Z., Tang, W., Clancy, Z., Cheung, C., Zhou, Z. Y. & Xie, J., Oct 22 2019, In : Blood Advances. 3, 20, p. 2986-2994 9 p.

Research output: Contribution to journalArticle

Open Access
5 Scopus citations

Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: A SEER-medicare analysis

Ailawadhi, S., Frank, R. D., Advani, P., Swaika, A., Temkit, M., Menghani, R., Sharma, M., Meghji, Z., Paulus, S., Khera, N. D., Hashmi, S. K., Paulus, A., Kakar, T. S., Hodge, D. O., Colibaseanu, D. T., Vizzini, M. R., Roy, V., Colon-Otero, G. & Chanan Khan, A. A., 2017, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

15 Scopus citations

Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

Kumar, S. K., LaPlant, B. R., Reeder, C. B., Roy, V., Halvorson, A. E., Buadi, F., Gertz, M. A., Bergsagel, P. L., Dispenzieri, A., Thompson, M. A., Crawley, J., Kapoor, P., Mikhael, J., Stewart, K., Hayman, S. R., Hwa, Y. L., Gonsalves, W., Witzig, T. E., Ailawadhi, S., Dingli, D. & 5 others, Go, R. S., Lin, Y., Rivera, C. E., Rajkumar, S. V. & Lacy, M. Q., Nov 17 2016, In : Blood. 128, 20, p. 2415-2422 8 p.

Research output: Contribution to journalArticle

31 Scopus citations

Re: FDG PET/CT Findings of Intracardiac Myeloid Sarcoma

Sahu, K. K., Gautam, A. & Ailawadhi, S., Nov 4 2016, (Accepted/In press) In : Clinical Nuclear Medicine.

Research output: Contribution to journalArticle

10 Scopus citations

Reactivation of Chagas disease in a bone marrow transplant patient: Case report and review of screening and management

Guiang, K. M. U., Cantey, P., Montgomery, S. P., Ailawadhi, S., Qvarnstrom, Y., Price, T. & Blodget, E., Dec 1 2013, In : Transplant Infectious Disease. 15, 6, p. E264-E267

Research output: Contribution to journalArticle

8 Scopus citations

Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRd

Chari, A., Richardson, P. G., Romanus, D., Dimopoulos, M. A., Sonneveld, P., Terpos, E., Hajek, R., Raju, A., Palumbo, A., Cain, L. E., Blazer, M., Huang, H., Farrelly, E. & Ailawadhi, S., Apr 2 2020, In : Expert Review of Hematology. 13, 4, p. 421-433 13 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant

Dholaria, B., Patel, R. J., Sluzevich, J. C., Ailawadhi, S. & Roy, V., Sep 6 2017, (Accepted/In press) In : Annals of Hematology. p. 1-2 2 p.

Research output: Contribution to journalArticle

3 Scopus citations

Representation of Minorities and Elderly Patients in Multiple Myeloma Clinical Trials

Duma, N., Azam, T., Riaz, I. B., Gonzalez-Velez, M., Ailawadhi, S. & Go, R., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

2 Scopus citations

Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment

Vidisheva, A. P., Wang, J., Spektor, T. M., Bitran, J. D., Lutzky, J., Tabbara, I. A., Ye, J. Z., Ailawadhi, S., Stampleman, L. V., Steis, R. G., Moezi, M. M., Swift, R. A., Maluso, T. M., Udd, K. A., Eshaghian, S., Nassir, Y. & Berenson, J. R., Apr 28 2017, (Accepted/In press) In : Supportive Care in Cancer. p. 1-8 8 p.

Research output: Contribution to journalArticle

2 Scopus citations

Second primary acute lymphoblastic leukemia in adults: A SEER analysis of incidence and outcomes

Swaika, A., Frank, R. D., Yang, D., Finn, L. E., Jiang, L., Advani, P., Chanan-Khan, A. A., Ailawadhi, S. & Foran, J. M., Jan 1 2017, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

14 Scopus citations

Serotonin syndrome caused by interaction between citalopram and fentanyl

Ailawadhi, S., Sung, K. W., Carlson, L. A. & Baer, M. R., Apr 1 2007, In : Journal of Clinical Pharmacy and Therapeutics. 32, 2, p. 199-202 4 p.

Research output: Contribution to journalArticle

49 Scopus citations

Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers

Lou, Y., Dholaria, B., Soyano, A., Hodge, D., Cochuyt, J., Manochakian, R., Ko, S. J., Thomas, M., Johnson, M. M., Patel, N. M., Miller, R. C., Adjei, A. A. & Ailawadhi, S., Jan 1 2018, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

6 Scopus citations

Survival trends in glioblastoma and association with treating facility volume

Aulakh, S., DeDeo, M. R., Free, J., Rosenfeld, S., Quinones-Hinojosa, A., Paulus, A., Manna, A., Manochakian, R., Chanan Khan, A. A. & Ailawadhi, S., Jan 1 2019, In : Journal of Clinical Neuroscience.

Research output: Contribution to journalArticle

3 Scopus citations

Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities

Ailawadhi, S., Azzouqa, A. G., Hodge, D., Cochuyt, J., Jani, P., Ahmed, S., Sher, T., Roy, V., Ailawadhi, M., Alegria, V. R., Manochakian, R., Vishnu, P., Grover, A., Abdulazeez, M. F., Paulus, A. & Chanan Khan, A. A., Jan 1 2019, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

1 Scopus citations
36 Scopus citations

Targeting CD38 enhances the antileukemic activity of ibrutinib in chronic lymphocytic leukemia

Manna, A., Aulakh, S., Jani, P., Ahmed, S., Akhtar, S., Coignet, M., Heckman, M., Meghji, Z., Bhatia, K., Sharma, A., Sher, T., Alegria, V., Malavasi, F., Chini, E. N., Chanan-Khan, A., Ailawadhi, S. & Paulus, A., Jan 1 2019, In : Clinical Cancer Research. 25, 13, p. 3974-3985 12 p.

Research output: Contribution to journalArticle

4 Scopus citations

Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD81 T-cell responses

Manna, A., Kellett, T., Aulakh, S., Lewis-Tuffin, L. J., Dutta, N., Knutson, K., Chini, E., Pinilla-Ibarz, J., Lamanna, N., Manochakian, R., Malavasi, F., Sher, T., Chanan-Khan, A. A., Ailawadhi, S. & Paulus, A., May 26 2020, In : Blood Advances. 4, 10, p. 2143-2157 15 p.

Research output: Contribution to journalArticle

Open Access

Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells

Paulus, A., Manna, A., Akhtar, S., Paulus, S. M., Sharma, M., Coignet, M. V., Jiang, L., Roy, V., Witzig, T. E., Ansell, S. M., Allan, J., Furman, R., Aulakh, S., Manochakian, R., Ailawadhi, S., Chanan-Khan, A. A. & Sher, T., Oct 2018, In : British journal of haematology. 183, 2, p. 196-211 16 p.

Research output: Contribution to journalArticle

5 Scopus citations

The Determinants of Palliative Care Use in Patients With Colorectal Cancer: A National Study

Colibaseanu, D. T., Osagiede, O., Spaulding, A., Frank, R. D., Merchea, A., Mathis, K. L., Parker, A. & Ailawadhi, S., Jan 1 2018, (Accepted/In press) In : American Journal of Hospice and Palliative Medicine.

Research output: Contribution to journalArticle

6 Scopus citations

Timeliness of initial therapy in multiple myeloma: Trends and factors affecting patient care

Kumar, V., Alhaj-Moustafa, M., Bojanini, L., Sher, T., Roy, V., Manochakian, R., Vishnu, P., Bodepudi, S., Shareef, Z., Ahmed, S., Jani, P., Paulus, A., Grover, A., Alegria, V. R., Ailawadhi, M., Chanan-Khan, A. & Ailawadhi, S., Apr 1 2020, In : Journal of oncology practice. 16, 4, p. E341-E349

Research output: Contribution to journalArticle

Treatment-free remission after second-line nilotinib treatment in patients with chronic myeloid leukemia in chronic phase results from a single-group, phase 2, open-label study

Mahon, F. X., Boquimpani, C., Kim, D. W., Benyamini, N., Clementino, N. C. D., Shuvaev, V., Ailawadhi, S., Lipton, J. H., Turkina, A. G., De Paz, R., Moiraghi, B., Nicolini, F. E., Dengler, J., Sacha, T., Takahashi, N., Fellague-Chebra, R., Acharya, S., Wong, S., Jin, Y. & Hughes, T. P., Apr 3 2018, In : Annals of Internal Medicine. 168, 7, p. 461-470 10 p.

Research output: Contribution to journalArticle

52 Scopus citations

Treatment of Immunoglobulin Light Chain Amyloidosis Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

Dispenzieri, A., Buadi, F., Kumar, S. K., Reeder, C. B., Sher, T., Lacy, M., Kyle, R. A., Mikhael, J. R., Roy, V., Leung, N., Grogan, M., Kapoor, P., Lust, J. A., Dingli, D. M., Go, R. S., Hwa, Y. L., Hayman, S. R., Fonseca, R., Ailawadhi, S., Bergsagel, P. L. & 6 others, Chanan Khan, A. A., Rajkumar, S. V., Russell, S. J., Stewart, A. K., Zeldenrust, S. R. & Gertz, M., Aug 1 2015, In : Mayo Clinic Proceedings. 90, 8, p. 1054-1081 28 p.

Research output: Contribution to journalArticle

69 Scopus citations

Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities

Ailawadhi, S., Frank, R. D., Sharma, M., Menghani, R., Temkit, M., Paulus, S., Khera, N. D., Hashmi, S., Advani, P., Swaika, A., Paulus, A., Aslam, N., Sher, T., Roy, V., Colon-Otero, G. & Chanan Khan, A. A., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

12 Scopus citations

Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia

Kumar, V., Ailawadhi, S., Bojanini, L., Mehta, A., Biswas, S., Sher, T., Roy, V., Vishnu, P., Marin-Acevedo, J., Alegria, V. R., Paulus, A., Aulakh, S., Iqbal, M., Manochakian, R., Tan, W., Chanan-Khan, A. & Ailawadhi, M., Oct 1 2019, In : Blood cancer journal. 9, 10, 75.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma

Kumar, V., Garg, M., Chandra, A. B., Mayorga, V. S., Ahmed, S. & Ailawadhi, S., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

1 Scopus citations

Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups

Ailawadhi, S., Swaika, A., Razavi, P., Yang, D. & Chanan Khan, A. A., Jan 1 2014, In : Blood Cancer Journal. 4, 9, e243.

Research output: Contribution to journalArticle

9 Scopus citations
18 Scopus citations